Cefoxitin Injection, Powder, For Solution
Product Images NDC 0143-9878

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cefoxitin (NDC 0143-9878). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Cefoxitin For Injection 1)

Chemical Structure (Cefoxitin For Injection 1)
Chemical structure diagram of cefoxitin, showing its molecular framework including a beta-lactam ring, sulfur atoms, and functional groups such as methoxy and acetamido moieties.*
FDA Label Image

Ndc 0143-9878-01 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only * Each Vial Contains Cefoxitin Sodium Equivalent To 1 G Cefoxitin. The Sodium Content Is 53.8 mg (2.3 Meq). For The Preparation Of Iv Solutions And The Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc (41ºf)). Store Dry Material Between 2º To 25ºc (36º To 77ºf). Avoid Exposure To Temperatures Above 50ºc (122ºf). Color Changes In Powder Or Solution Do Not Affect Potency. Date/time _________________ / _________________ (Cefoxitin For Injection 2)

Ndc 0143-9878-01 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only * Each Vial Contains Cefoxitin Sodium Equivalent To 1 G Cefoxitin. The Sodium Content Is 53.8 mg (2.3 Meq). For The Preparation Of Iv Solutions And The Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc (41ºf)). Store Dry Material Between 2º To 25ºc (36º To 77ºf). Avoid Exposure To Temperatures Above 50ºc (122ºf). Color Changes In Powder Or Solution Do Not Affect Potency. Date/time _________________ / _________________ (Cefoxitin For Injection 2)
Label for Cefoxitin Injection, USP 1 g/vial, an intravenous powder for solution by Hikma Pharmaceuticals USA Inc. The label includes dosage information, storage instructions, manufacturer and distributor details, and barcodes. It specifies the product as for IV use only and prescription use only.*
FDA Label Image

25 X 1 G* Vials Ndc 0143-9878-25 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only (Cefoxitin For Injection 3)

25 X 1 G* Vials Ndc 0143-9878-25 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only (Cefoxitin For Injection 3)
Cefoxitin 1 g vial label for injection USP, powder for solution. The label indicates intravenous use only with a package size of 25 vials of 1 g each. Manufactured by Hikma Farmacêutica (Portugal) and distributed by West-Ward in Eatontown, NJ. Includes storage instructions and a note that the product is prescription-only (Rx only).*
FDA Label Image

25 X 1 G* Vials Ndc 0143-9878-25 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only *each Vial Contains Cefoxitin Sodium Equivalent To 1 G Cefoxitin. The Sodium Content Is 53.8 mg (2.3 Meq). For The Preparation Of I.v. Solutions And Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc). Store Dry Material Between 2-25ºc (36-77ºf). Avoid Exposure To Temperatures Above 50ºc. Color Changes In Powder Or Solution Do Not Affect Potency. (Cefoxitin For Injection 4)

25 X 1 G* Vials Ndc 0143-9878-25 Cefoxitin For Injection, Usp 1 G*/vial For Iv Use Only Rx Only *each Vial Contains Cefoxitin Sodium Equivalent To 1 G Cefoxitin. The Sodium Content Is 53.8 mg (2.3 Meq). For The Preparation Of I.v. Solutions And Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc). Store Dry Material Between 2-25ºc (36-77ºf). Avoid Exposure To Temperatures Above 50ºc. Color Changes In Powder Or Solution Do Not Affect Potency. (Cefoxitin For Injection 4)
Cefoxitin 2 g/vial injection, powder for solution, for intravenous use. The label shows the product name Cefoxitin for Injection USP, strength 2 g per vial, and includes storage instructions to keep dry material between 2°C and 25°C and avoid exposure above 50°C. Labeler information includes Hikma Farmacêutica (Portugal) and West-Ward Pharmaceutical Corp., Eatontown, NJ. The NDC code 0143-9877-01 is visible along with a barcode.*
FDA Label Image

Ndc 0143-9877-01 Cefoxitin For Injection, Usp 2 G*/vial For Iv Use Only Rx Only * Each Vial Contains Cefoxitin Sodium Equivalent To 2 G Cefoxitin. The Sodium Content Is 107.6 mg (4.6 Meq). For The Preparation Of Iv Solutions And The Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc (41ºf)). Store Dry Material Between 2º To 25ºc (36º To 77ºf). Avoid Exposure To Temperatures Above 50ºc (122ºf). Color Changes In Powder Or Solution Do Not Affect Potency. Date/time _________________ / _________________ (Cefoxitin For Injection 5)

Ndc 0143-9877-01 Cefoxitin For Injection, Usp 2 G*/vial For Iv Use Only Rx Only * Each Vial Contains Cefoxitin Sodium Equivalent To 2 G Cefoxitin. The Sodium Content Is 107.6 mg (4.6 Meq). For The Preparation Of Iv Solutions And The Usual Adult Dosage: See Package Insert. After Initial Constitution, The Solution Maintains Satisfactory Potency For 6 Hours At Room Temperature Or For 1 Week Under Refrigeration (below 5ºc (41ºf)). Store Dry Material Between 2º To 25ºc (36º To 77ºf). Avoid Exposure To Temperatures Above 50ºc (122ºf). Color Changes In Powder Or Solution Do Not Affect Potency. Date/time _________________ / _________________ (Cefoxitin For Injection 5)
Label for Cefoxitin injection powder, USP, 2 g per vial, for intravenous use. Packaging states 25 vials of 2 g each. The labeler is Hikma Pharmaceuticals USA Inc., distributed by West-Ward in Eatontown, NJ. Instructions indicate it is for prescription use only, with storage and preparation details provided.*
FDA Label Image

25 X 2 G* Vials Ndc 0143-9877-25 Cefoxitin For Injection, Usp 2 G*/vial For Iv Use Only Rx Only (Cefoxitin For Injection 6)

25 X 2 G* Vials Ndc 0143-9877-25 Cefoxitin For Injection, Usp 2 G*/vial For Iv Use Only Rx Only (Cefoxitin For Injection 6)
Label for Cefoxitin injection powder for solution, showing GTIN barcode, Serial Number (SN), Expiration Date (EXP), and Lot Number (LOT) fields. The label is intended for intravenous use and includes placeholder alphanumeric data for manufacturing and traceability information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.